What development phase is Bl-S786R in?

Bl-S786R is FDA-approved (marketed).

What is the generic name of Bl-S786R?

CEFORANIDE is the generic (nonproprietary) name of Bl-S786R.

Last reviewed 2026-04-20 · How we verify

Bl-S786R (CEFORANIDE)

FDA-approved approved Small molecule Quality 15/100

At a glance

Generic name	CEFORANIDE
Drug class	ceforanide
Target	Bacterial penicillin-binding protein, Penicillin-binding protein 1A
Modality	Small molecule
Therapeutic area	Metabolic
Phase	FDA-approved
First approval	1984

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Bl-S786R CI brief — competitive landscape report
Bl-S786R updates RSS · CI watch RSS